The General Assembly of HUNT Biosciences have  on October 15 agreed to invest additional NOK 9 mill in the company.  The investment is made by the current owners; NTNU, Helse Midt-Norge and North Trøndelag County and will allow the company to initiate projects with industry partners in the area of Pharmacogenomics and health economy.